Up-regulation of BAIAP2L1 was observed in clear cell Renal Carcinoma [74] (confirmed also by our data on a surgically removed ccRCC [75]), in lung cancer [76] and recently even in prostate cancer [77]. This evidence concerns the gene BAIAP2L1 and nonpapillary renal cell carcinoma.